Cancer care cost trends in the United States: 1998 to 2012

Cancer
James A LeeErin Duggan Butto

Abstract

The authors examine trends in spending on cancer from 1998 through 2012, including cancer care costs, prevalence, and cases by payer, and discuss the results within the context of a prior analysis and recent health policy and programmatic changes. Condition-specific distribution of expenditures from the Medical Expenditure Panel Survey, supplemented with results from the National Nursing Home Survey and other data sources, was used as the basis for allocating the Personal Health Care components of the National Health Expenditure Accounts among conditions. Cancer care expenditures grew at an annualized rate of 2.9% from 1998 to 2012. The share of expenditures for hospital-based care declined to a low of 48% during 2007 through 2009. Professional and clinical services' shares declined substantially between 2007 to 2009 and 2010 to 2012 when the hospital share increased. Treated prevalence decreased for all payers between the first and last study periods with the exception of private payers (11.2% increase). Out-of-pocket expenditures declined to 4.7%, whereas Medicare's share increased slightly. Medication expenditures increased, notably within retail and mail order settings. The previous rapid growth of cancer prevalence and exp...Continue Reading

References

Dec 22, 2007·CA: a Cancer Journal for Clinicians·Elizabeth WardAhmedin Jemal
Jun 12, 2008·Journal of the National Cancer Institute·Joan L WarrenMartin L Brown
Jan 30, 2009·The New England Journal of Medicine·Peter B Bach
Feb 26, 2009·Health Affairs·Charles RoehrigJenny Bryant
Jul 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J MeropolUNKNOWN American Society of Clinical Oncology
Jun 1, 2010·Research in Social & Administrative Pharmacy : RSAP·David A MottAbhijit S Gadkari
Jun 22, 2010·Cancer·Florence K TangkaEric A Finkelstein
Jul 2, 2010·Journal of Oncology Practice·Maurie Markman, Ryan Luce
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ya-Chen Tina ShihLowell Schnipper
Jan 1, 2012·Medicare & Medicaid Research Review·Didem BernardStephen Heffler
Jun 4, 2014·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Oct 8, 2014·Health Affairs·Dana P Goldman, Tomas Philipson
Feb 19, 2015·Journal of Oncology Practice·Ronald M KlinePatrick H Conway
May 20, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ya-Chen Tina ShihThomas J Smith
Sep 5, 2015·Journal of Economic Behavior & Organization·Christopher C AfendulisRichard G Frank

❮ Previous
Next ❯

Citations

Jun 24, 2016·Journal of Surgical Oncology·Ravinder KangSandra L Wong
Oct 22, 2016·Journal of the National Cancer Institute·Cheryl K AlticeK Robin Yabroff
Apr 28, 2017·Journal of Managed Care & Specialty Pharmacy
Feb 8, 2019·Journal of Medical Economics·Arpamas SeetasithChakkarin Burudpakdee
Apr 23, 2019·Journal of Oncology Practice·Martin C TomMatthew C Ward
Aug 5, 2017·Cancer Causes & Control : CCC·Amelie G Ramirez, Ian M Thompson
Dec 6, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Robin YabroffYa-Chen Tina Shih
Nov 1, 2017·JCO Clinical Cancer Informatics·Chadi Nabhan, Bruce A Feinberg
Jul 8, 2020·International Journal of Environmental Research and Public Health·Mattia AltiniIlaria Massa
Nov 16, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·K Robin YabroffXuesong Han
Dec 1, 2020·Journal of Geriatric Oncology·Lauren E WilsonMichaela A Dinan
Oct 16, 2020·Research in Social & Administrative Pharmacy : RSAP·Taehwan Park, Monica Hwang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.